Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Astellas Pharma Inc. (ALPMY)

Other OTC - Other OTC Delayed Price. Currency in USD
15.16-0.01 (-0.07%)
At close: 03:46PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 1/26/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.56
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 317.96
52 Week Low 312.82
50-Day Moving Average 315.15
200-Day Moving Average 314.90

Share Statistics

Avg Vol (3 month) 374.97k
Avg Vol (10 day) 390.03k
Shares Outstanding 51.85B
Implied Shares Outstanding 6N/A
Float 81.74B
% Held by Insiders 10.00%
% Held by Institutions 10.05%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.41
Forward Annual Dividend Yield 42.97%
Trailing Annual Dividend Rate 342.00
Trailing Annual Dividend Yield 3276.86%
5 Year Average Dividend Yield 42.39
Payout Ratio 475.33%
Dividend Date 3Dec 17, 2017
Ex-Dividend Date 4Mar 28, 2022
Last Split Factor 2125:100
Last Split Date 3Apr 01, 2014

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 30, 2022
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 8.74%
Operating Margin (ttm)15.90%

Management Effectiveness

Return on Assets (ttm)5.68%
Return on Equity (ttm)8.09%

Income Statement

Revenue (ttm)1.35T
Revenue Per Share (ttm)733.58
Quarterly Revenue Growth (yoy)17.10%
Gross Profit (ttm)1.04T
EBITDA 313.39B
Net Income Avi to Common (ttm)118.21B
Diluted EPS (ttm)0.60
Quarterly Earnings Growth (yoy)-19.10%

Balance Sheet

Total Cash (mrq)336.76B
Total Cash Per Share (mrq)184.77
Total Debt (mrq)4.87B
Total Debt/Equity (mrq)0.32
Current Ratio (mrq)1.34
Book Value Per Share (mrq)746.73

Cash Flow Statement

Operating Cash Flow (ttm)266.19B
Levered Free Cash Flow (ttm)249.71B
Advertisement
Advertisement